The IBD SmartSelect Composite Rating for Erie Indemnity Cl A rose from 94 to 98 Friday.
The revised score means the stock currently tops 98% of all other stocks in terms of key performance metrics and technical strength.
Erie Indemnity Cl A is trading within the buy zone from a 411.72 entry from a double bottom.
Looking For The Best Stocks To Buy And Watch? Start Here
The stock has a 94 EPS Rating, which means its recent quarterly and longer-term annual earnings growth is outpacing 94% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
The company reported 37% earnings growth for Q4. Revenue growth came in at 13%, down from 16% in the previous quarter. The company's next quarterly report is expected on or around Apr. 24.
Erie Indemnity Cl A holds the No. 5 rank among its peers in the Insurance-Brokers industry group. Kingstone is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
